Medicare approval of a solid organ transplant program means CMS has found that a transplant program inside a Medicare-participating hospital meets the transplant conditions of participation in 42 CFR 482.72 through 482.104. This page is for transplant program administrators and quality leaders who are launching, expanding or maintaining a heart, lung, liver, kidney, pancreas or intestine program. Integral Healthcare Solutions (IHS) organizes your transplant program's governance records and certification evidence; your transplant clinicians own selection and protocols.

Last reviewed: October 2026.

What is Medicare transplant program approval?

42 CFR 482.68 states: "A transplant program located within a hospital that has a Medicare provider agreement must meet the conditions of participation specified in §§ 482.72 through 482.104 in order to be granted approval from CMS to provide transplant services" (42 CFR Part 482, Subpart E). CMS describes the scope: "A transplant program is located in a Medicare-approved hospital and provides transplantation services for the following types of solid organs: heart, lung, liver, kidney, pancreas, or intestine" (CMS Organ Transplant Program page).

The governing texts, in the versions reviewed for this page:

• 42 CFR Part 482, Subpart E, §§ 482.68–482.104, eCFR current as of September 30, 2026 (eCFR). The sections include § 482.72 (OPTN membership), § 482.74 (notification to CMS), § 482.76 (pediatric transplants), § 482.78 (emergency preparedness), § 482.80 (data submission, clinical experience and outcome requirements for initial approval), and the process requirements in §§ 482.90–482.104, among them § 482.96 (QAPI), § 482.98 (human resources), § 482.100 (organ procurement) and § 482.104 (kidney).
• 42 CFR 488.61, "Special procedures for approval and re-approval of organ transplant programs" (eCFR).
• CMS State Operations Manual, Appendix X, "Guidance to Surveyors: Organ Transplant Programs," Rev. 240, issued May 1, 2026 (CMS).
• The CMS Organ Transplant Program page (CMS).

Approval is organ by organ. Appendix X states: "Hospitals may have more than one transplant program, and each program must be surveyed and approved individually" (SOM Appendix X).

Who needs it and what triggers it

This work is for hospitals that run, or plan to run, a solid organ transplant program under Medicare. The usual triggers:

• A new organ program. "A transplant program, including a kidney transplant program, may submit a request to CMS for Medicare approval at any time" (42 CFR 488.61(a), eCFR). Volume is the first test, with exceptions: "To be considered for initial approval, an organ-specific transplant program must generally perform 10 transplants over a 12-month period" (42 CFR 482.80(b), eCFR). Section 482.80(d) exempts heart-lung and pancreas programs from the clinical experience requirement for those transplants and exempts a program requesting initial approval to perform pediatric transplants from it before its request. "A kidney transplant center may submit a request for initial approval after performing at least 3 transplants over a 12-month period" (42 CFR 488.61(a)(6), eCFR). CMS also reviews outcomes: it will not consider patient and graft survival acceptable if observed survival is below expected and all three thresholds in 482.80(c)(2)(ii) are crossed. Which test applies to your organ program is a question to settle before you plan around a volume number.
• An unannounced survey. Appendix X states that "all transplant program surveys must be unannounced" (SOM Appendix X), so the governance file has to be current at all times.
• Data deadlines. "No later than 90 days after the due date established by the OPTN, a transplant program must submit to the OPTN at least 95 percent of required data on all transplants (deceased and living donor) it has performed" (42 CFR 482.80(a), eCFR).

How IHS helps

IHS's process runs against 42 CFR 482.72–482.104 and SOM Appendix X:

1. Gap assessment. IHS reviews program governance and documents against the conditions, using questionnaires on committees, agreements, staffing and outcome review.
2. Document and evidence mapping. IHS builds a crosswalk from each condition to the program's evidence.
3. Drafting. IHS drafts governance documents, committee record templates, an agreement register that includes the OPO agreement, QAPI and adverse-event procedures, and outcome-review procedures, for your program leadership to review and adopt.
4. Mock review. IHS runs a rehearsal review on the Appendix X protocol.
5. Readiness support. IHS drafts correspondence, such as the content of the approval request, for your hospital's authorized representative to sign and submit.

What your hospital supplies: program documents, the OPO agreement, committee records, outcome data, and the transplant clinicians who own patient and living donor selection and clinical protocols.

The limit: recipient and donor selection, clinical protocols and outcome interpretation are clinical work outside IHS's depth.

Related IHS pages: Compliance Services and Accreditation Consulting.

What to have ready

Each item below ties to 42 CFR 482 Subpart E or 42 CFR 488.61 (eCFR current as of September 30, 2026) or to SOM Appendix X (Rev. 240, May 1, 2026).

• The hospital's Medicare provider I.D. number (42 CFR 488.61(a), eCFR).
• The names of the designated primary transplant surgeon and primary transplant physician (42 CFR 488.61(a), eCFR).
• "A statement from the OPTN that the center has complied with all data submission requirements" (42 CFR 488.61(a), eCFR).
• A person authorized to sign the request, "for example, a chief executive officer" (42 CFR 488.61(a), eCFR).
• Evidence that the hospital is "a member of and abides by the rules and requirements of the Organ Procurement and Transplantation Network (OPTN)" (42 CFR 482.72, eCFR).
• A transplant volume log: generally 10 transplants over 12 months, or at least 3 for a kidney program, subject to the exceptions in 42 CFR 482.80(d) for heart-lung, pancreas and pediatric requests (42 CFR 482.80(b),(d); 42 CFR 488.61(a)(6)). Also have the program's most recent SRTR one-year patient and graft survival data, which CMS reviews under 42 CFR 482.80(c) and 488.61(a)(2).
• A data submission record showing at least 95 percent of required data submitted to the OPTN within 90 days of the due date (42 CFR 482.80(a), eCFR).
• A written OPO agreement that "identifies specific responsibilities for the hospital and for the OPO with respect to organ recovery and organ allocation" (42 CFR 482.100, eCFR).
• A "written, comprehensive, data-driven QAPI program designed to monitor and evaluate performance of all transplantation services, including services provided under contract or arrangement" (42 CFR 482.96, eCFR).
• Data that are already complete and correct, because under Appendix X the § 482.80 condition is "evaluated by the surveyor off-site, prior to the survey... the program may not submit any additional or corrected data during the survey to change the compliance determination" (SOM Appendix X).

When these are together, the introductory call is the place to start.

How it compares

Transplant programs answer to more than one layer of requirements. The layers below are not alternatives to each other; each applies on its own terms.

We did not review private accreditation or certification options for transplant programs, so this page does not compare them.

What it costs

CMS does not publish a fee schedule for transplant program approval on the pages we reviewed; fees depend on scope. OPTN membership fees are not covered on this page. IHS scopes each engagement after a free introductory call.

What this is not

• This page is not legal or clinical advice. IHS does not set recipient or donor selection criteria, write clinical protocols or interpret outcomes.
• IHS does not sign or submit the approval request and does not correspond with CMS, the OPTN or your OPO for you. Your authorized representative signs and your hospital submits; IHS drafts.
• IHS does not guarantee CMS approval or a survey result.

Frequently asked questions

What does Medicare approval of a transplant program require?

42 CFR 482.68 states that a transplant program in a hospital with a Medicare provider agreement must meet the conditions of participation in 42 CFR 482.72 through 482.104 to be granted CMS approval. Those conditions cover OPTN membership, data submission, clinical experience and outcomes, QAPI, human resources, organ procurement and more.

Which solid organ transplant programs need CMS approval, and is each organ program approved separately?

The CMS Organ Transplant Program page lists heart, lung, liver, kidney, pancreas and intestine programs. SOM Appendix X states that a hospital may have more than one transplant program and that each program must be surveyed and approved individually.

How many transplants does a new program need before it can apply for Medicare approval?

42 CFR 482.80(b) states that an organ-specific program must generally perform 10 transplants over a 12-month period to be considered for initial approval. Section 482.80(d) exempts heart-lung and pancreas programs from that requirement for those transplants, and exempts a pediatric request from it before the request is made. Under 42 CFR 488.61(a)(6), a kidney transplant center may request initial approval after at least 3 transplants over a 12-month period. CMS also reviews outcomes under 42 CFR 482.80(c).

What goes into the request to CMS for initial transplant program approval?

42 CFR 488.61(a) requires a request signed by a person authorized to represent the center, such as a chief executive officer. It must include the hospital's Medicare provider I.D. number, the names of the designated primary transplant surgeon and primary transplant physician, and a statement from the OPTN that the center has complied with all data submission requirements. IHS can draft the request content; your authorized representative signs and submits it.

Are CMS transplant program surveys announced or unannounced, and what do surveyors review?

SOM Appendix X states that all transplant program surveys must be unannounced. It also states that the data, clinical experience and outcome condition in 42 CFR 482.80 is evaluated off-site before the survey, and that the program may not submit additional or corrected data during the survey to change the compliance determination.

What does the OPO agreement have to contain?

42 CFR 482.100 requires the program to ensure its hospital has a written agreement for the receipt of organs with an OPO designated by the Secretary. The agreement must identify specific responsibilities for the hospital and for the OPO with respect to organ recovery and organ allocation.

What does a transplant program QAPI program need?

42 CFR 482.96 requires a written, comprehensive, data-driven QAPI program designed to monitor and evaluate performance of all transplantation services. That includes services provided under contract or arrangement. IHS drafts QAPI procedures for your program leadership to adopt.

What are the human resources requirements for a transplant program?

The human resources condition is 42 CFR 482.98. The approval request under 42 CFR 488.61(a) must name the designated primary transplant surgeon and primary transplant physician. IHS maps your staffing records to the condition during the gap assessment.

How do OPTN membership and CMS approval relate?

They are separate layers, and both apply. 42 CFR 482.72 requires the program to be in a transplant hospital that is a member of and abides by the rules of the OPTN. CMS approval also depends on OPTN data: 42 CFR 488.61(a) requires a statement from the OPTN on data submission.

What can a compliance consultant do for a transplant program, and what stays with transplant clinicians?

IHS runs a gap assessment against 42 CFR 482.72 through 482.104 and SOM Appendix X, builds the evidence crosswalk, drafts governance documents, committee templates, the agreement register and QAPI and outcome-review procedures, and runs a mock review. Recipient and donor selection, clinical protocols and outcome interpretation stay with your transplant clinicians.